SV Health Investors Promotes A.J. Rossi to Partner on Healthcare Growth-Buyout TeamBOSTON & LONDON, December 19, 2024-- SV Health Investors (“SV”), a leading healthcare-focused private equity firm, is pleased to announce the promotion of A.J. Rossi to Partner on the firm’s Growth-Buyout team. In this new role, A.J.

SV Health Investors推动A.J.Rossi成为医疗保健增长并购团队的合作伙伴波士顿和伦敦，2024年12月19日——SV Health Investors（“SV”）是一家专注于医疗保健的领先私募股权公司，很高兴宣布将A.J.Rossi提升为该公司增长并购团队的合作伙伴。在这个新角色中，A.J。

will continue to lead investments and manage the SV portfolio, while helping to drive the firm’s growth initiatives across the healthcare sector..

将继续领导投资和管理SV投资组合，同时帮助推动公司在医疗保健领域的增长计划。。

Since joining SV Health Investors in 2022, A.J. has played a pivotal role in the firm’s successful investment strategy, focusing on identifying high-impact opportunities in the healthcare sector. With a deep understanding of market dynamics and a proven track record of working closely with portfolio companies to accelerate growth, A.J.

自2022年加入SV Health Investors以来，A.J.在公司成功的投资战略中发挥了关键作用，专注于确定医疗保健领域的高影响力机会。凭借对市场动态的深刻理解以及与投资组合公司密切合作以加速增长的良好记录，a.J。

has contributed significantly to the firm’s portfolio value creation and operational success..

为公司的投资组合价值创造和运营成功做出了重大贡献。。

“We are thrilled to announce A.J.’s promotion to Partner,” said Greg Madden, Managing Partner at SV Health Investors. “His dedication, expertise, and collaborative approach have made a lasting impact on our firm and the companies we work with. A.J. has consistently demonstrated leadership and vision in identifying and nurturing healthcare companies with transformative potential, and we look forward to seeing him continue to thrive in this expanded role.”.

SV Health Investors管理合伙人格雷格·马登（GregMadden）表示：“我们很高兴宣布A.J.晋升为Partner。”。“他的奉献精神、专业知识和协作方式对我们的公司和我们合作的公司产生了持久的影响。a.J.在识别和培育具有变革潜力的医疗保健公司方面一直表现出领导力和远见，我们期待着看到他在这个扩大的角色中继续茁壮成长。”。

In addition to his investment responsibilities, A.J. will also take an active role in enhancing SV’s strategic direction, working alongside the leadership team and other Partners to further strengthen the firm’s position as a key player in the healthcare private equity space.

除了投资职责外，A.J.还将在加强SV的战略方向方面发挥积极作用，与领导团队和其他合作伙伴合作，进一步加强公司在医疗保健私人股本领域的关键角色地位。

“I am honored to take on this new role and to continue working with such a talented and dedicated team,” said A.J. “SV Health Investors has been a catalyst for positive change in healthcare, and I look forward to helping accelerate that mission as we partner with innovative companies that are shaping the future of the industry.”.

。

A.J. brings a wealth of experience in healthcare investing, having worked on transactions across healthcare services, outsourced medical device and pharma services, and healthcare IT verticals. Current and past healthcare Board directorships and portfolio company involvement include Robling Medical, Packaging Compliance Labs, Hightop Health, Nira Medical Group, Ria Heath, Medbio, Velosity, and HemaSource.

A、 J.在医疗保健投资方面拥有丰富的经验，曾从事医疗保健服务、外包医疗器械和制药服务以及医疗保健IT垂直领域的交易。目前和过去的医疗保健董事会董事和投资组合公司包括Robling Medical、Packaging Compliance Labs、Hightop Health、Nira Medical Group、Ria Heath、Medbio、Velosity和HemaSource。

Previously, A.J. was a Principal and co-lead of the healthcare sector at private equity firm Graham Partners. A.J. holds a bachelor’s degree from the University of Pennsylvania..

此前，A.J.是私人股本公司Graham Partners医疗保健部门的负责人和联席主管。A、 J.拥有宾夕法尼亚大学学士学位。。

About SV Health Investors:

关于SV Health Investors：

SV Health Investors is a private equity firm dedicated to investments in the healthcare and life sciences sector. Founded in 1993 with offices in Boston and London, SV manages approximately $2.0B across multiple investment strategies.

。SV成立于1993年，在波士顿和伦敦设有办事处，管理着大约20亿美元的多种投资策略。

SV’s dedicated healthcare Growth-Buyout strategy seeks to partner with experienced management teams to accelerate the success of innovative healthcare companies across healthcare services, outsourced medtech and pharma services, medical products, and healthcare IT. SV combines decades of healthcare transaction and operating experience to drive long-term value creation and realize the triple aim of healthcare – higher quality care, accessible to more patients, at a lower cost..

SV致力于医疗保健增长收购战略，旨在与经验丰富的管理团队合作，加速医疗保健服务、外包医疗技术和制药服务、医疗产品和医疗保健IT等创新型医疗保健公司的成功。SV结合数十年的医疗保健交易和运营经验，推动长期价值创造，实现医疗保健的三重目标-更高质量的护理，让更多患者以更低的成本获得。。

For more information, visit www.svhealthinvestors.com.Contact:

有关更多信息，请访问www.svhealthinestors.com.Contact：

Media contact:

媒体联系人：

Dylan Arpey

迪伦·阿尔佩

SV Health Investors

SV健康投资者

darpey@svhealthinvestors.com

darpey@svhealthinvestors.com